BBT Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

BBT Capital Management’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-120,000	Closed	-$10.7M	–	111
2017 Q1	$10.7M	Buy	+120,000	New	+$9.87M	1.85%	21

Other funds holding MJN

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Envestnet Asset Management

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

BBT Capital Management's MJN Position: Q2 2017 in Review

BBT Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 120,000 shares — an estimated $10.7M sold.

BBT Capital Management first reported a position in MJN in Q1 2017 and held it in 1 quarter. The position peaked at $10.7M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

BBT Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
BBT Capital Management sold 120,000 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $10.7M.
BBT Capital Management first reported a position in Mead Johnson Nutrition Company in Q1 2017 and held it in 1 quarter.
BBT Capital Management's Mead Johnson Nutrition Company position peaked at $10.7M in Q1 2017.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on BBT Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.